Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.

about

Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.

P2860

Q55277025-787215B1-FFAA-4924-AF47-6DE5BA63548C Q55689191-23F4EEA6-7C02-4C2C-B94F-FFEDE29C26F7

P2860

Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.

Item

http://www.wikidata.org/entity/Q55166388

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinical management of seroneg ...... rthritis: A comparative study.

@en

Clinical management of seroneg ...... rthritis: A comparative study.

@nl

type

Item

label

Clinical management of seroneg ...... rthritis: A comparative study.

@en

Clinical management of seroneg ...... rthritis: A comparative study.

@nl

prefLabel

Clinical management of seroneg ...... rthritis: A comparative study.

@en

Clinical management of seroneg ...... rthritis: A comparative study.

@nl

P1476

Clinical management of seroneg ...... arthritis: A comparative study

@en

P2093

Sang-Tae Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.

Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis.

Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

P304

e0195550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0195550

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kwang-Hoon Lee

P577

2018-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29624625

http://www.w3.org/2001/XMLSchema#string

P932

5889180

http://www.w3.org/2001/XMLSchema#string

Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.

about

P2860

P2860

Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932